08.05.2017
- Major drug makers Allergan and Novartis are collaborating to test a new combination therapy for non-alcoholic steatohepatitis (NASH), a progressive form of fatty liver disease said...
20.03.2017
- US drugmaker Marathon Pharmaceuticals has sold all rights to its Duchenne muscular dystrophy (DMD) drug Emflaza (deflazacort) to PTC Therapeutics in a deal that could be...
13.03.2017
- After acquiring the remaining stake in Bamboo Therapeutics, a privately held gene therapy group based in Chapel Hill, North Carolina, USA, last year in a drive to be a major player...
16.01.2017
- UK-based Silence Therapeutics has acquired an 8.4% equity stake in US biotech group Arrowhead Pharmaceuticals to potentially advance progress in novel RNA therapeutics. Silence...
24.11.2016
- Irish drugmaker Allergan has beefed up its pipeline for neurodegenerative disorders with the acquisition of US-based Chase Pharmaceuticals. Under the terms of the deal, Allergan...
04.10.2016
- Continuing its recent spending spree, Allergan has bought Akarna Therapeutics for $50 million in cash. The privately held biopharmaceutical company, which has dual headquarters in...
31.05.2016
- Large innovative US pharmaceutical companies will continue seeking bolt-on acquisitions as the need for larger transactions has declined, says the ratings agency Fitch, adding that...
03.09.2015
- In September 2014, Merck announced the €13.1 billion acquisition of Sigma-Aldrich, which by mid-August has received antitrust clearance from all relevant jurisdictions including...
